Compositions and methods for prevention and treatment of hearing loss
US11883491B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2018 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Sep 3, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/03
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions using an inhibitor of EGFR signaling for prevention or an inhibitor of EGFR signaling and a nucleic acid molecule encoding an atonal-associated factor for treatment of hearing loss are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.